Lithuania has decided not to purchase the COVID vaccine from Moderna. The country will additionally purchase the drug produced by Pfizer and BioNTech.
This decision was made by the Lithuanian government.
According to the country’s Minister of Health, the step was caused by the fact that Moderna raised the price of its products by 33% and refuses to supply on previous conditions.
The first batch of Moderna in the amount of 2.4 thousand doses arrived in Lithuania on January 12.
Lithuania was to buy about 500 thousand doses of vaccine Moderna, 1.85 million doses of vaccine BioNTech and Pfizer, 1.86 million doses of the preparation of the British-Swedish company AstraZeneca and 1.24 million doses of Janssen, a division of Johnson & Johnson.
Recall that at the end of December 2020, a new outbreak of coronavirus on a mink farm was recorded in Lithuania. The animals could have been infected by workers who were sick with tuberculosis.